+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hormonal Contraceptives Global Market Report 2021: COVID-19 Impact and Recovery to 2030

  • ID: 5319135
  • Report
  • April 2021
  • Region: Global
  • The Business Research Company

FEATURED COMPANIES

  • Afaxys Inc.
  • Allergan
  • Ansell Limited
  • Church & Dwight Co
  • Famy care
  • HLL Lifecare Limited
  • MORE
Hormonal Contraceptives Global Market Report 2021: COVID-19 Impact and Recovery to 2030 provides strategists, marketers and senior management with the critical information they need to assess the global hormonal contraceptives market as it emerges from the COVID-19 shut down.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:

Where is the largest and fastest growing market for the hormonal contraceptives? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Hormonal Contraceptives Market Global Report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:
1) By Product: Oral Contraceptive Pills; Injectable Birth Control; Emergency Contraceptive Pills; Vaginal Rings; Others
2) By End Users: Hospitals; Homecare Settings; Gynaecology Centers; Clinics; Ambulatory surgical centers
3) By Hormones: Progestin-Only; Combined Hormones
4) By Distribution Channel: Drug Stores; Gynaecology/ Fertility Clinics; E-Commerce; Others

Companies Mentioned: Bayer AG; Merck & Co. Inc.; Pfizer; Allergan; Afaxys Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Afaxys Inc.
  • Allergan
  • Ansell Limited
  • Church & Dwight Co
  • Famy care
  • HLL Lifecare Limited
  • MORE
1. Executive Summary

2. Hormonal Contraceptives Market Characteristics

3. Hormonal Contraceptives Market Trends And Strategies

4. Impact Of COVID-19 on Hormonal Contraceptives

5. Hormonal Contraceptives Market Size And Growth
5.1. Global Hormonal Contraceptives Historic Market, 2015-2020, $ Billion
5.1.1. Drivers of the Market
5.1.2. Restraints on The Market
5.2. Global Hormonal Contraceptives Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers of the Market
5.2.2. Restraints on the Market

6. Hormonal Contraceptives Market Segmentation
6.1. Global Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Oral Contraceptive Pills
  • Injectable Birth Control
  • Emergency Contraceptive Pills
  • Vaginal Rings
  • Others
6.2. Global Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospitals
  • Homecare Settings
  • Gynaecology Centers
  • Clinics
  • Ambulatory surgical centers
6.3. Global Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Progestin-Only
  • Combined Hormones
6.4. Global Hormonal Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Drug Stores
  • Gynaecology/ Fertility Clinics
  • E-Commerce
  • Others
7. Hormonal Contraceptives Market Regional And Country Analysis
7.1. Global Hormonal Contraceptives Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Hormonal Contraceptives Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Hormonal Contraceptives Market
8.1. Asia-Pacific Hormonal Contraceptives Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8.3. Asia-Pacific Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Hormonal Contraceptives Market
9.1. China Hormonal Contraceptives Market Overview
9.2. China Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
9.3. China Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Hormonal Contraceptives Market
10.1. India Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
10.2. India Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Hormonal Contraceptives Market
11.1. Japan Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11.2. Japan Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Hormonal Contraceptives Market
12.1. Australia Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12.2. Australia Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Hormonal Contraceptives Market
13.1. Indonesia Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13.2. Indonesia Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Hormonal Contraceptives Market
14.1. South Korea Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14.2. South Korea Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Hormonal Contraceptives Market
15.1. Western Europe Hormonal Contraceptives Market Overview
15.2. Western Europe Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15.3. Western Europe Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Hormonal Contraceptives Market
16.1. UK Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16.2. UK Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Hormonal Contraceptives Market
17.1. Germany Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17.2. Germany Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Hormonal Contraceptives Market
18.4. France Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18.5. France Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Hormonal Contraceptives Market
19.1. Eastern Europe Hormonal Contraceptives Market Overview
19.2. Eastern Europe Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19.3. Eastern Europe Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Hormonal Contraceptives Market
20.1. Russia Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20.2. Russia Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Hormonal Contraceptives Market
21.1. North America Hormonal Contraceptives Market Overview
21.2. North America Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21.3. North America Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Hormonal Contraceptives Market
22.1. USA Hormonal Contraceptives Market Overview
22.2. USA Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22.3. USA Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Hormonal Contraceptives Market
23.1. South America Hormonal Contraceptives Market Overview
23.2. South America Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23.3. South America Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Hormonal Contraceptives Market
24.1. Brazil Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24.2. Brazil Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Hormonal Contraceptives Market
25.1. Middle East Hormonal Contraceptives Market Overview
25.2. Middle East Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25.3. Middle East Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Hormonal Contraceptives Market
26.1. Africa Hormonal Contraceptives Market Overview
26.2. Africa Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26.3. Africa Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Hormonal Contraceptives Market Competitive Landscape And Company Profiles
27.1. Hormonal Contraceptives Market Competitive Landscape
27.2. Hormonal Contraceptives Market Company Profiles
27.2.1. Bayer AG
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Merck & Co. Inc.
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Pfizer
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Allergan
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Afaxys Inc.
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance

28. Hormonal Contraceptives Pipeline Analysis

29. Key Mergers And Acquisitions In The Hormonal Contraceptives Market

30. Hormonal Contraceptives Market Future Outlook and Potential Analysis

31. Appendix
31.1. Abbreviations
31.2. Currencies
31.3. Research Inquiries
31.4. About the Publisher
31.5. Copyright And Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Afaxys Inc.
  • Allergan
  • Ansell Limited
  • Church & Dwight Co
  • Famy care
  • HLL Lifecare Limited
  • MORE
Major players in the hormonal contraceptives market are Bayer AG, Merck & Co. Inc., Pfizer, Allergan and Afaxys Inc.

The global hormonal contraceptives market is expected to grow from $16.16 billion in 2020 to $18.1 billion in 2021 at a compound annual growth rate (CAGR) of 12%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $21.52 billion in 2025 at a CAGR of 4.4%.

The hormonal contraceptives market consists of sale of hormonal contraceptives and related services. Hormonal contraceptives are used as a birth control method that acts on the endocrine system of the human body.

Companies are innovating to manufacture chewable low dose oral contraceptives that reduce side effects. Chewable contraceptive initiative was an attempt to reduce side effects while at the same time making it easier for the patients to get into a daily regimen of using this contraceptive. The pill is already being sold as an over-the-counter product. Some of the top companies that produce and sell chewable low-dose oral contraceptives, for instance, are Lupin pharmaceuticals, Walter Chilcott and Watson pharmaceuticals.

Increased awareness about the benefits and use of contraceptives is a major factor driving the hormonal contraceptives market. According to the World Health Organization (WHO), 16 million girls worldwide aged 15-19 give birth every year which accounts to approximately 11% of all births globally. In order to prevent these unplanned births global awareness programs such as ""Its your life, its your future"" by the WHO and world contraception day were initiated. The London Summit on Family Planning urged governments, international agencies, and other private sector to commit to improving access to voluntary family planning. This gave rise to the global partnership, Family Planning 2020 (FP2020). FP2020 has created a momentum worldwide on issues such as access to contraceptives, more innovation, and greater accountability in family planning efforts. For example India will have spent USD$3 billion by 2020 to spread awareness improve family planning in the country. Moreover, in 2020, according to the United Nations Department of Economic and Social Affairs, about 1.1 billion women aged between 15 and 49 considered to have a need for family planning.

Manufacturers in the hormonal contraceptives market should abide by many strict regulations with regards to labeling hormonal contraceptives, and are all supervised by regulatory authorities. For instance, the US FDA has drafted a new set of guidance and labelling recommendations in the hormonal contraceptives market, and have to be in accordance with the 2006 physician labeling rule (PLR) and the 2014 pregnancy and lactation labeling rule (PLLR). The main purpose of PLR is to enhance the safety and usage of the particular prescribed drug by providing healthcare providers clear prescription information (PI). The FDA mandates all hormonal contraceptives to mention the effectiveness of the drug from preventing STDs, and any other relevant information regarding effectiveness of the drug. The FDA considers that communicating information regarding pregnancy rates to the users of these contraceptive drugs is essential for safety and effective usage.

The market for hormonal contraceptive drugs is restrained by the growing use of biologics in place of traditional chemical drugs. Biologics are the medicines containing one or more substances derived from a biological source like micro-organisms, animal cells or human cells. The ability to interact with specific targets puts these medicines above any other drugs, thus hampering the market of chemical hormonal contraceptive drugs.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Bayer AG
  • Merck & Co. Inc.
  • Pfizer
  • Allergan
  • Afaxys Inc.
  • Teva Pharma Industries Ltd.
  • Agile Therapeutics
  • HLL Lifecare Limited
  • Lupin Pharmaceuticals Inc.
  • Piramal Healthcare Limited
  • Cipla Limited
  • Glenmark Pharmaceuticals
  • Novartis AG
  • Sun Pharmaceutical Industries Ltd.
  • Apothecus Pharmaceutical Corporation
  • Amgen
  • Ansell Limited
  • Church & Dwight Co
  • Johnson & Johnson
  • Mayer Laboratories
  • Famy care
  • Mylan Laboratories
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll